Lista de obras - Eva Segelov - Dominio Público Uruguay

A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in australia.

artículo científico publicado en 2014

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

artículo científico publicado en 2016

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.

artículo científico publicado en 2018

Alterations of the Birt-Hogg-Dubé gene (BHD) in sporadic colorectal tumours

artículo científico publicado en 2003

Chemotherapy made easier

artículo científico publicado en 1993

Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience

artículo científico publicado en 1994

Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care

scientific article published on 12 September 2019

Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

artículo científico publicado en 2015

Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.

artículo científico publicado en 2014

Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008.

scientific article published on January 2010

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

artículo científico publicado en 2014

Current opinion on optimal treatment for colorectal cancer.

artículo científico

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

artículo científico publicado en 2015

Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review

artículo científico publicado en 2017

Follow-up for resected gastroenteropancreatic neuroendocrine tumours (GEP-NETs): A practice survey of the Commonwealth Neuroendocrine collaboration (CommNETs) and North American Neuroendocrine Tumor Society (NANETS).

artículo científico publicado en 2018

High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma--Letter

scientific article published on 01 February 2011

ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

artículo científico publicado en 2016

Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration

artículo científico publicado en 2016

Identifying and prioritising gaps in colorectal cancer trials research in Australia

artículo científico publicado en 2012

Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres

artículo científico publicado en 2018

Improving the impact of didactic resident training with online spaced education.

artículo científico publicado en 2013

Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence.

artículo científico publicado en 2018

JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer

artículo científico publicado en 2015

Long term response to chemotherapy in patients with visceral metastatic melanoma

artículo científico publicado en 1994

Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors

scientific article published on 01 March 2018

Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer

artículo científico publicado en 2014

Management of advanced gastric cancer.

artículo científico publicado en 2012

Mechanisms determining sensitivity to cisplatin in three mutant Chinese hamster ovary cell lines

artículo científico publicado en 1998

Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer

artículo científico publicado en 2005

PTEN mutations are common in sporadic microsatellite stable colorectal cancer

artículo científico publicado en 2004

Physical activity and fitness in women with metastatic breast cancer

artículo científico publicado en 2014

Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer

artículo científico publicado en 2012

Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue.

artículo científico publicado en 2017

Reasons to try ‘RIME’

artículo científico publicado en 2007

Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors

scientific article published on 01 April 2018

Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial

artículo científico publicado en 1992

Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects

scientific article published on 15 July 2020

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study

artículo científico publicado en 2016

Risk factors, epidemiology, screening, and prognostic factors in female genital cancer

artículo científico publicado el 1 de octubre de 1992

Role of human papillomaviruses in esophageal squamous cell carcinoma

artículo científico publicado en 2012

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

scientific article published on 13 November 2018

The Economic Impact on Australian Patients with Neuroendocrine Tumours

artículo científico publicado en 2020

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors

artículo científico publicado en 2017

The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer

artículo científico publicado en 2021

The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis

artículo científico publicado en 2013

The impact of histological review on clinical management of testicular cancer

artículo científico publicado en 1993

The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials

artículo científico publicado en 2014

Lista de obras de Eva Segelov

A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in australia.

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.

Alterations of the Birt-Hogg-Dubé gene (BHD) in sporadic colorectal tumours

Chemotherapy made easier

Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience

Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care

Correction: Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.

Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008.

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

Current opinion on optimal treatment for colorectal cancer.

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review

Follow-up for resected gastroenteropancreatic neuroendocrine tumours (GEP-NETs): A practice survey of the Commonwealth Neuroendocrine collaboration (CommNETs) and North American Neuroendocrine Tumor Society (NANETS).

High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma--Letter

ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration

Identifying and prioritising gaps in colorectal cancer trials research in Australia

Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres

Improving the impact of didactic resident training with online spaced education.

Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence.

JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer

Long term response to chemotherapy in patients with visceral metastatic melanoma

Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors

Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer

Management of advanced gastric cancer.

Mechanisms determining sensitivity to cisplatin in three mutant Chinese hamster ovary cell lines

Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer

PTEN mutations are common in sporadic microsatellite stable colorectal cancer

Physical activity and fitness in women with metastatic breast cancer

Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer

Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue.

Reasons to try ‘RIME’

Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors

Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial

Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study

Risk factors, epidemiology, screening, and prognostic factors in female genital cancer

Role of human papillomaviruses in esophageal squamous cell carcinoma

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

The Economic Impact on Australian Patients with Neuroendocrine Tumours

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors

The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer

The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis

The impact of histological review on clinical management of testicular cancer

The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials